6 research outputs found
Pneumonia in Immunosuppressed Patients
PluÄne infekcije važan su uzrok morbiditeta i mortaliteta u imunosuprimiranih bolesnika. U posljednje se vrijeme spektar imunokompromitiranih bolesnika znatno proÅ”irio zbog poveÄanja broja bolesnika koji primaju imunosupresivnu terapiju nakon transplantacije organa ili u sklopu lijeÄenja autoimunosnih upalnih bolesti, bolesnika s malignim i hematoloÅ”kim bolestima te onih s infekcijom virusom humane imunodeficijencije. Imunosupresija može nastati kao posljedica neutropenije, oÅ”teÄenja humoralne ili staniÄne imunosti ili primjene kortikosteroida. Rizik od infekcije pojedinim patogenima ovisi o vrsti imunosnog deficita te stupnju i trajanju imunosupresije. Uz uobiÄajene patogene oportunistiÄki patogeni mogu uzrokovati teÅ”ke infekcije u imunosuprimiranog bolesnika. TakoÄer, u tih su bolesnika Äeste istodobne multiple infekcije. Rano postavljanje specifiÄne mikrobioloÅ”ke dijagnoze i zapoÄinjanje ciljanoga mikrobioloÅ”kog lijeÄenja mogu smanjiti morbiditet i mortalitet.Pulmonary infections are a significant cause of morbidity and mortality in immunocompromised hosts. In recent years, the spectrum of immunocompromised patients has significantly increased as a result of a growing number of patients receiving immunosuppressive drug regimens for the management of organ transplantation or autoimmune inflammatory conditions, patients with malignancies, hematologic diseases and patients with human immunodeficiency virus infection. Immunosuppression may be a result of a lack of neutrophil-mediated immunity, as well as a lack of humoral or cellular immunity or the use of glucocorticoids. The type of pathogens causing the infection is directly related to the underlying type of immunodeficiency, and the degree and duration of the immunosuppression. In addition to common pathogens, organisms of low native virulence can cause severe infections in immunocompromised hosts. Multiple simultaneous infections are also common in this population. Early specific microbiologic diagnoses and initiating the target therapy can help reduce morbidity and mortality. Whenever possible, the level of immunosuppression should be decreased, to improve the outcomes
Pneumonia in Immunosuppressed Patients
PluÄne infekcije važan su uzrok morbiditeta i mortaliteta u imunosuprimiranih bolesnika. U posljednje se vrijeme spektar imunokompromitiranih bolesnika znatno proÅ”irio zbog poveÄanja broja bolesnika koji primaju imunosupresivnu terapiju nakon transplantacije organa ili u sklopu lijeÄenja autoimunosnih upalnih bolesti, bolesnika s malignim i hematoloÅ”kim bolestima te onih s infekcijom virusom humane imunodeficijencije. Imunosupresija može nastati kao posljedica neutropenije, oÅ”teÄenja humoralne ili staniÄne imunosti ili primjene kortikosteroida. Rizik od infekcije pojedinim patogenima ovisi o vrsti imunosnog deficita te stupnju i trajanju imunosupresije. Uz uobiÄajene patogene oportunistiÄki patogeni mogu uzrokovati teÅ”ke infekcije u imunosuprimiranog bolesnika. TakoÄer, u tih su bolesnika Äeste istodobne multiple infekcije. Rano postavljanje specifiÄne mikrobioloÅ”ke dijagnoze i zapoÄinjanje ciljanoga mikrobioloÅ”kog lijeÄenja mogu smanjiti morbiditet i mortalitet.Pulmonary infections are a significant cause of morbidity and mortality in immunocompromised hosts. In recent years, the spectrum of immunocompromised patients has significantly increased as a result of a growing number of patients receiving immunosuppressive drug regimens for the management of organ transplantation or autoimmune inflammatory conditions, patients with malignancies, hematologic diseases and patients with human immunodeficiency virus infection. Immunosuppression may be a result of a lack of neutrophil-mediated immunity, as well as a lack of humoral or cellular immunity or the use of glucocorticoids. The type of pathogens causing the infection is directly related to the underlying type of immunodeficiency, and the degree and duration of the immunosuppression. In addition to common pathogens, organisms of low native virulence can cause severe infections in immunocompromised hosts. Multiple simultaneous infections are also common in this population. Early specific microbiologic diagnoses and initiating the target therapy can help reduce morbidity and mortality. Whenever possible, the level of immunosuppression should be decreased, to improve the outcomes
Cystic Fibrosis ā results of CFTR modulators in Croatia
CistiÄna fibroza najÄeÅ”Äa je nasljedna bolest, koja skraÄuje životni vijek, a uzrokuje je defekt u genu za transmembranski regulator provodljivosti cistiÄne fibroze (eng. cystic fibrosis transmembrane regulator ā CFTR). PoremeÄena je homeostaza elektrolita, Å”to se oÄituje simptomima u viÅ”e organskih sustava. PluÄne manifestacije, s kroniÄnim infekcijama, upalom i, na kraju, respiratornim zatajenjem, ostaju i dalje najvažnija prijetnja životnom vijeku bolesnika. Do prije jednog desetljeÄa bilo je dostupno samo simptomatsko lijeÄenje. Od 2012. g. dostupno
je lijeÄenje tzv. modulatorima CFTR-proteina i njihovim kombinacijama za osobe s cistiÄnom fibrozom koje nose razliÄite varijante CFTR-gena. Pojavom tih lijekova uvelike se promijenila perspektiva i kvaliteta života ljudi s cistiÄnom fibrozom, ali postavljeni i novi izazovi u vezi s dugoroÄnim komplikacijama, pitanje eventualnog smanjenja konvencionalnog lijeÄenja, ali i financiranja terapije, koja je mnogim bolesnicima nedostupna. Iznesene su baziÄne spoznaje o cistiÄnoj fibrozi i funkciji CFTR-proteina, klasifikaciji varijanata CFTR-gena, moguÄnostima lijeÄenja CFTR-modulatorima te osnovni ishodi lijeÄenja bolesnika s cistiÄnom fibrozom u Hrvatskoj, gdje se ta terapija primjenjuje od jeseni 2021. godine.Cystic fibrosis, the most frequent lifespan shortening hereditary disease in Caucasians, is caused by a defect in the CFTR (cystic fibrosis transmembrane regulator) gene. Disturbed electrolyte homeostasis leads to the development of different symptoms in multiple organs. Pulmonary manifestations with chronic infections and inflammation result in respiratory failure and remain the most important life-shortening factor. Until recently only symptomatic treatment was available. In year 2012. a new treatment approach with small molecules that modulate the CFTR protein was introduced. Different combinations of CFTR modulators are applicable to certain patients carrying different variants of the CFTR gene. CFTR modulators made a huge difference in the quality of life and perspectives of people with cystic fibrosis. At the same time, new challenges emerged regarding long term complications and possible reduction of conventional treatment options, as well as financial issues that are an obstacle
to the use of these drugs for many patients. This paper brings basic insight into cystic fibrosis, the function of CFTR protein, the classification of CFTR gene variants and possibilities of treatment with CFTR modulators as well as basic outcomes of CFTR modulators treatment in Croatia, where this therapy was introduced in autumn 2021
TLR7 gene and protein in non-small cell lung cancer
UVOD: Karcinom pluÄa vodeÄi je uzrok smrti od malignih bolesti Å”irom svijeta. KroniÄna
upala, kroniÄna izloženost Å”tetnim tvarima, naruÅ”ena funkcija uroÄene i steÄene imunosti uz
genetske mutacije dovode do promjene u staniÄnom mikrookoliÅ”u i smatraju se najÄeÅ”Äim
uzrokom ove teÅ”ke bolesti. Ovim istraživanjem želimo dokazati povezanost genetiÄkih
biomarkera (polimorfizama) s nastankom i razvojem karcinoma pluÄa nemalih stanica
(NSCLC). -----
ISPITANICI I METODE: U istraživanje je ukljuÄeno 450 ispitanika s dijagnozom NSCLC-a
te 1283 zdravih ispitanika. Genotipizacijom je odreÄena uÄestalost polimorfizama TLR7 gena
i njhova povezanost s TNM statusom. Metodom RT-PCR ispitana je razina ekspresije TLR7
gena i IFNĪ³ u uzorcima tumorskog tkiva uz analizu limfocita u tumorskom mikrookoliÅ”u. -----
REZULTATI: U ispitivanoj populaciji pronaÅ”li smo dva najÄeÅ”Äa polimofizma TLR7 gena;
rs5935436 CT i rs12843803 TG koji su povezani s nastankom NSCLC-a. Prisutnost
polimorfnog biljega rs12843803 TG statistiÄki je znaÄajno povezana sa stupnjem
zahvaÄenosti limfnih Ävorova. Rezultati analize profiliranja tumorskog mikrookoliÅ”a pokazali
su da je stupanj infiltracije CD8+ limfocita T u tumorsku stromu statistiÄki znaÄajno poviÅ”en
o genotipu rs5935436 CT. -----
ZAKLJUÄAK: Rezultati ovog istraživanja pokazuju povezanost nasljedno uvjetovane
poveÄane ekspresije TLR7 gena, rizika za razvoj karcinoma pluÄa nemalih stanica i obilježja
tumorskog okoliŔa, Ŕto može poslužiti kao osnova za daljnja istraživanja protutumorske
terapije usmjerene na funkciju TLR7 gena.INTRODUCTION: Lung cancer is the leading cause of death in the group of malignant
diseases worldwide. Chronic inflammation, chronic exposure to harmful substances, impaired
innate and acquired immune function with genetic mutations lead to changes in the cellular
microenvironment and they are considered to be the most common cause of this severe
disease. We want to prove the association of cancergenetic biomarkers (polymorphisms) with
non-small cell lung cancer (NSCLC). -----
SUBJECTS AND METHODS: The study included 450 patients with NSCLC and 1283
healthy respondents. We used genotyping to determine the frequency of TLR7 gene
polymorphisms and their association with TNM status. The level of TLR7 gene and IFNĪ³
expression in tumor tissue samples were examined by RT-PCR with analysis of the tumor
microenvironment. -----
RESULTS: In our study rs5935436 CT and rs12843803 TG were the most common
polymorphisms of the TLR7 gene associated with the formation of NSCLC. The presence of
the polymorphic marker rs12843803 TG was significantly associated with the degree of
lymph node metastases. We analysed the tumor microenvironment and showed that the
degree of CD8 infiltration into the tumor stroma was significantly higher in patients with
rs5935436 CT genotype. -----
CONCLUSION: This study confirmed an association between hereditary increased TLR7
gene expression, risk of non-small cell lung cancer and tumor microenvironment. This data
can be useful for the further research on anticancer therapy focused on TLR7 gene function
TLR7 gene and protein in non-small cell lung cancer
UVOD: Karcinom pluÄa vodeÄi je uzrok smrti od malignih bolesti Å”irom svijeta. KroniÄna
upala, kroniÄna izloženost Å”tetnim tvarima, naruÅ”ena funkcija uroÄene i steÄene imunosti uz
genetske mutacije dovode do promjene u staniÄnom mikrookoliÅ”u i smatraju se najÄeÅ”Äim
uzrokom ove teÅ”ke bolesti. Ovim istraživanjem želimo dokazati povezanost genetiÄkih
biomarkera (polimorfizama) s nastankom i razvojem karcinoma pluÄa nemalih stanica
(NSCLC). -----
ISPITANICI I METODE: U istraživanje je ukljuÄeno 450 ispitanika s dijagnozom NSCLC-a
te 1283 zdravih ispitanika. Genotipizacijom je odreÄena uÄestalost polimorfizama TLR7 gena
i njhova povezanost s TNM statusom. Metodom RT-PCR ispitana je razina ekspresije TLR7
gena i IFNĪ³ u uzorcima tumorskog tkiva uz analizu limfocita u tumorskom mikrookoliÅ”u. -----
REZULTATI: U ispitivanoj populaciji pronaÅ”li smo dva najÄeÅ”Äa polimofizma TLR7 gena;
rs5935436 CT i rs12843803 TG koji su povezani s nastankom NSCLC-a. Prisutnost
polimorfnog biljega rs12843803 TG statistiÄki je znaÄajno povezana sa stupnjem
zahvaÄenosti limfnih Ävorova. Rezultati analize profiliranja tumorskog mikrookoliÅ”a pokazali
su da je stupanj infiltracije CD8+ limfocita T u tumorsku stromu statistiÄki znaÄajno poviÅ”en
o genotipu rs5935436 CT. -----
ZAKLJUÄAK: Rezultati ovog istraživanja pokazuju povezanost nasljedno uvjetovane
poveÄane ekspresije TLR7 gena, rizika za razvoj karcinoma pluÄa nemalih stanica i obilježja
tumorskog okoliŔa, Ŕto može poslužiti kao osnova za daljnja istraživanja protutumorske
terapije usmjerene na funkciju TLR7 gena.INTRODUCTION: Lung cancer is the leading cause of death in the group of malignant
diseases worldwide. Chronic inflammation, chronic exposure to harmful substances, impaired
innate and acquired immune function with genetic mutations lead to changes in the cellular
microenvironment and they are considered to be the most common cause of this severe
disease. We want to prove the association of cancergenetic biomarkers (polymorphisms) with
non-small cell lung cancer (NSCLC). -----
SUBJECTS AND METHODS: The study included 450 patients with NSCLC and 1283
healthy respondents. We used genotyping to determine the frequency of TLR7 gene
polymorphisms and their association with TNM status. The level of TLR7 gene and IFNĪ³
expression in tumor tissue samples were examined by RT-PCR with analysis of the tumor
microenvironment. -----
RESULTS: In our study rs5935436 CT and rs12843803 TG were the most common
polymorphisms of the TLR7 gene associated with the formation of NSCLC. The presence of
the polymorphic marker rs12843803 TG was significantly associated with the degree of
lymph node metastases. We analysed the tumor microenvironment and showed that the
degree of CD8 infiltration into the tumor stroma was significantly higher in patients with
rs5935436 CT genotype. -----
CONCLUSION: This study confirmed an association between hereditary increased TLR7
gene expression, risk of non-small cell lung cancer and tumor microenvironment. This data
can be useful for the further research on anticancer therapy focused on TLR7 gene function
TLR7 gene and protein in non-small cell lung cancer
UVOD: Karcinom pluÄa vodeÄi je uzrok smrti od malignih bolesti Å”irom svijeta. KroniÄna
upala, kroniÄna izloženost Å”tetnim tvarima, naruÅ”ena funkcija uroÄene i steÄene imunosti uz
genetske mutacije dovode do promjene u staniÄnom mikrookoliÅ”u i smatraju se najÄeÅ”Äim
uzrokom ove teÅ”ke bolesti. Ovim istraživanjem želimo dokazati povezanost genetiÄkih
biomarkera (polimorfizama) s nastankom i razvojem karcinoma pluÄa nemalih stanica
(NSCLC). -----
ISPITANICI I METODE: U istraživanje je ukljuÄeno 450 ispitanika s dijagnozom NSCLC-a
te 1283 zdravih ispitanika. Genotipizacijom je odreÄena uÄestalost polimorfizama TLR7 gena
i njhova povezanost s TNM statusom. Metodom RT-PCR ispitana je razina ekspresije TLR7
gena i IFNĪ³ u uzorcima tumorskog tkiva uz analizu limfocita u tumorskom mikrookoliÅ”u. -----
REZULTATI: U ispitivanoj populaciji pronaÅ”li smo dva najÄeÅ”Äa polimofizma TLR7 gena;
rs5935436 CT i rs12843803 TG koji su povezani s nastankom NSCLC-a. Prisutnost
polimorfnog biljega rs12843803 TG statistiÄki je znaÄajno povezana sa stupnjem
zahvaÄenosti limfnih Ävorova. Rezultati analize profiliranja tumorskog mikrookoliÅ”a pokazali
su da je stupanj infiltracije CD8+ limfocita T u tumorsku stromu statistiÄki znaÄajno poviÅ”en
o genotipu rs5935436 CT. -----
ZAKLJUÄAK: Rezultati ovog istraživanja pokazuju povezanost nasljedno uvjetovane
poveÄane ekspresije TLR7 gena, rizika za razvoj karcinoma pluÄa nemalih stanica i obilježja
tumorskog okoliŔa, Ŕto može poslužiti kao osnova za daljnja istraživanja protutumorske
terapije usmjerene na funkciju TLR7 gena.INTRODUCTION: Lung cancer is the leading cause of death in the group of malignant
diseases worldwide. Chronic inflammation, chronic exposure to harmful substances, impaired
innate and acquired immune function with genetic mutations lead to changes in the cellular
microenvironment and they are considered to be the most common cause of this severe
disease. We want to prove the association of cancergenetic biomarkers (polymorphisms) with
non-small cell lung cancer (NSCLC). -----
SUBJECTS AND METHODS: The study included 450 patients with NSCLC and 1283
healthy respondents. We used genotyping to determine the frequency of TLR7 gene
polymorphisms and their association with TNM status. The level of TLR7 gene and IFNĪ³
expression in tumor tissue samples were examined by RT-PCR with analysis of the tumor
microenvironment. -----
RESULTS: In our study rs5935436 CT and rs12843803 TG were the most common
polymorphisms of the TLR7 gene associated with the formation of NSCLC. The presence of
the polymorphic marker rs12843803 TG was significantly associated with the degree of
lymph node metastases. We analysed the tumor microenvironment and showed that the
degree of CD8 infiltration into the tumor stroma was significantly higher in patients with
rs5935436 CT genotype. -----
CONCLUSION: This study confirmed an association between hereditary increased TLR7
gene expression, risk of non-small cell lung cancer and tumor microenvironment. This data
can be useful for the further research on anticancer therapy focused on TLR7 gene function